Flynn James E

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 76% 68% 82%
Transactions
69 29% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -30%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Flynn James E's trades of Larimar Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-02 2026-02-27
B Purchase
58,659 +6.6%
269.91
US$3,557,637 		58,659 +6.6% 269.91 US$3,557,637
2026-03-02 2026-02-27
B Purchase
34,297 +37.6%
227.16
US$848,474 		34,297 +37.6% 227.16 US$848,474
2026-03-02 2026-02-27
B Purchase
38,474 -45.9%
398.42
US$1,045,533 		38,474 -45.9% 398.42 US$1,045,533
2026-03-02 2026-02-27
B Purchase
1,084,010 +11.4%
5.00
US$5,420,050 		1,084,010 +11.4% 5.00 US$5,420,050
2025-11-24 2025-11-24
US Nuvalent Inc (NUVL)
S Sale
371,287 -4.3%
95.45
US$35,437,488 		371,287 -4.3% 95.45 US$35,437,488
2025-11-24 2025-11-24
US Nuvalent Inc (NUVL)
S Sale
371,287 -4.3%
95.45
US$35,437,488 		371,287 -4.3% 95.45 US$35,437,488
2025-08-04 2025-07-31
B Purchase
2,599,932 +55.1%
3.20
US$8,319,782 		2,599,932 +55.1% 3.20 US$8,319,782
2025-08-04 2025-07-31
B Purchase
3,387,539 +55.1%
3.20
US$10,840,125 		3,387,539 +55.1% 3.20 US$10,840,125
2025-08-04 2025-07-31
B Purchase
3,387,529 +55.1%
3.20
US$10,840,093 		3,387,529 +55.1% 3.20 US$10,840,093
2025-07-01 2025-06-27
S Sale
370,074 -7.0%
18.46
US$6,831,566 		370,074 -7.0% 18.46 US$6,831,566
2025-07-01 2025-06-27
S Sale
370,075 -7.0%
18.46
US$6,831,584 		370,075 -7.0% 18.46 US$6,831,584
2024-11-13 2024-11-12
S Sale
9,553 -0.2%
17.77
US$169,757 		9,553 -0.2% 17.77 US$169,757
2024-11-13 2024-11-12
S Sale
9,554 -0.2%
17.77
US$169,775 		9,554 -0.2% 17.77 US$169,775
2024-11-13 2024-11-12
S Sale
7,854 -0.1%
17.16
US$134,775 		7,854 -0.1% 17.16 US$134,775
2024-11-13 2024-11-12
S Sale
7,853 -0.1%
17.16
US$134,757 		7,853 -0.1% 17.16 US$134,757
2024-11-13 2024-11-11
S Sale
223,632 -4.1%
18.15
US$4,058,921 		223,632 -4.1% 18.15 US$4,058,921
2024-11-13 2024-11-11
S Sale
223,632 -4.1%
18.15
US$4,058,921 		223,632 -4.1% 18.15 US$4,058,921
2024-11-13 2024-11-11
S Sale
40,596 -0.7%
17.45
US$708,400 		40,596 -0.7% 17.45 US$708,400
2024-11-13 2024-11-11
S Sale
40,596 -0.7%
17.45
US$708,400 		40,596 -0.7% 17.45 US$708,400
2024-10-24 2024-10-22
US Nuvalent Inc (NUVL)
S Sale
1,000,000 -10.3%
97.75
US$97,750,000 		1,000,000 -10.3% 97.75 US$97,750,000
2024-10-24 2024-10-22
US Nuvalent Inc (NUVL)
S Sale
1,000,000 -10.3%
97.75
US$97,750,000 		1,000,000 -10.3% 97.75 US$97,750,000
2024-09-17 2024-09-17
B Purchase
35,000 +4.1%
18.00
US$630,000 		35,000 +4.1% 18.00 US$630,000
2024-09-17 2024-09-17
B Purchase
35,000 +4.1%
18.00
US$630,000 		35,000 +4.1% 18.00 US$630,000
2024-03-12 2024-03-12
S Sale
114,906 -1.0%
10.70
US$1,229,494 		114,906 -1.0% 10.70 US$1,229,494
2024-03-12 2024-03-11
S Sale
88,040 -0.8%
11.13
US$979,885 		88,040 -0.8% 11.13 US$979,885
2024-03-12 2024-03-11
S Sale
94,567 -0.8%
10.92
US$1,032,672 		94,567 -0.8% 10.92 US$1,032,672
2024-03-12 2024-03-08
S Sale
4,495 -0.0%
11.03
US$49,580 		4,495 -0.0% 11.03 US$49,580
2024-03-12 2024-03-08
S Sale
47,992 -0.4%
10.92
US$524,073 		47,992 -0.4% 10.92 US$524,073
2024-02-16 2024-02-16
B Purchase
1,430,205 +51.5%
8.74
US$12,499,992 		1,430,205 +51.5% 8.74 US$12,499,992
2024-02-16 2024-02-16
B Purchase
1,430,206 +30.3%
8.74
US$12,500,000 		1,430,206 +30.3% 8.74 US$12,500,000
2024-02-16 2024-02-16
B Purchase
1,430,206 +30.3%
8.74
US$12,500,000 		1,430,206 +30.3% 8.74 US$12,500,000
2022-12-30 2022-12-30
US Oncorus Inc (ONCR)
S Sale
15,220 -5.1%
0.27
US$4,109 		15,220 -5.1% 0.27 US$4,109
2022-12-30 2022-12-30
US Oncorus Inc (ONCR)
S Sale
61,826 -5.1%
0.27
US$16,693 		61,826 -5.1% 0.27 US$16,693
2022-12-30 2022-12-30
US Oncorus Inc (ONCR)
S Sale
61,826 -5.1%
0.27
US$16,693 		61,826 -5.1% 0.27 US$16,693
2022-12-30 2022-12-29
US Oncorus Inc (ONCR)
S Sale
15,538 -4.9%
0.26
US$4,040 		15,538 -4.9% 0.26 US$4,040
2022-12-30 2022-12-29
US Oncorus Inc (ONCR)
S Sale
63,108 -4.9%
0.26
US$16,408 		63,108 -4.9% 0.26 US$16,408
2022-12-30 2022-12-29
US Oncorus Inc (ONCR)
S Sale
63,107 -4.9%
0.26
US$16,408 		63,107 -4.9% 0.26 US$16,408
2022-12-30 2022-12-28
US Oncorus Inc (ONCR)
S Sale
6,096 -1.9%
0.25
US$1,524 		6,096 -1.9% 0.25 US$1,524
2022-12-30 2022-12-28
US Oncorus Inc (ONCR)
S Sale
24,757 -1.9%
0.25
US$6,189 		24,757 -1.9% 0.25 US$6,189
2022-12-30 2022-12-28
US Oncorus Inc (ONCR)
S Sale
24,757 -1.9%
0.25
US$6,189 		24,757 -1.9% 0.25 US$6,189
2022-12-27 2022-12-27
US Oncorus Inc (ONCR)
S Sale
7,136 -2.2%
0.27
US$1,927 		7,136 -2.2% 0.27 US$1,927
2022-12-27 2022-12-27
US Oncorus Inc (ONCR)
S Sale
28,977 -2.2%
0.27
US$7,824 		28,977 -2.2% 0.27 US$7,824
2022-12-27 2022-12-27
US Oncorus Inc (ONCR)
S Sale
28,977 -2.2%
0.27
US$7,824 		28,977 -2.2% 0.27 US$7,824
2022-12-27 2022-12-22
US Oncorus Inc (ONCR)
S Sale
909 -0.3%
0.28
US$255 		909 -0.3% 0.28 US$255
2022-12-27 2022-12-22
US Oncorus Inc (ONCR)
S Sale
3,693 -0.3%
0.28
US$1,034 		3,693 -0.3% 0.28 US$1,034